Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Small molecule IM boosts hair growth by changing stem cell metabolism.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

New small molecule drugs could help treat hair loss.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.